"Richard Pazdur had clashed with Trump officials on the legality and pace of their initiatives. His sudden retirement adds to the recent upheaval at FDA."
"The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job.
Pazdur privately mused last month about retiring from the Food and Drug Administration or returning to his old job at the agency as he raised concerns about the legality and pace of agency plans to expedite drug decisions, The Washington Post previously reported.
Pazdur’s retirement follows tensions with FDA Commissioner Marty Makary, who has touted multiple initiatives aimed at boosting the agency’s efficiency. Pazdur had questioned Makary’s plans to significantly shorten review times for drugs developed by companies that are aligned with the country’s priorities, such as efforts to address unmet medical needs or boost domestic manufacturing."
Rachel Roubein and Dan Diamond report for the Washington Post December 2, 2025.
SEE ALSO:
"RFK Jr.’s Vaccine Advisers Plan Biggest Change Yet To Childhood Schedule" (Washington Post)
Advertisement 
